申请人:BioChem Pharma, Inc.
公开号:US06369066B1
公开(公告)日:2002-04-09
This invention relates to single enantiomers of novel cis-substituted 1,3-oxathiolanes, of the formula (I):
wherein;
R1 is hydrogen, and R2 is cytosine or 5-fluorocytosine;
and pharmaceutically acceptable salts and esters thereof.
This invention also relates to pharmaceutical compositions containing them and to the use of these compounds as antiviral agents, particularly in combination therapy.
这项发明涉及一种新型顺式取代的单对映体1,3-噁硫环己烷,化学式为(I):其中;R1为氢,R2为胞嘧啶或5-氟胞嘧啶;以及其药学上可接受的盐和酯。这项发明还涉及含有它们的药物组合物,以及将这些化合物用作抗病毒剂,特别是在联合疗法中的用途。